C Oberhoff

Summary

Affiliation: University of Essen
Country: Germany

Publications

  1. ncbi Pharmacokinetics (PK) of a liposomal encapsulated fraction containing doxorubicin and of doxorubicin released from the liposomal capsule after intravenous infusion of Caelyx/Doxil
    R A Hilger
    Department of Internal Medicine (Cancer Research, University of Essen Medical School, West German Cancer Center, Essen, Germany
    Int J Clin Pharmacol Ther 43:588-9. 2005
  2. ncbi Recombinant human erythropoietin in the treatment of chemotherapy-induced anemia and prevention of transfusion requirement associated with solid tumors: a randomized, controlled study
    C Oberhoff
    Center for Gynecology and Obstetrics, University Hospital, Essen, Germany
    Ann Oncol 9:255-60. 1998
  3. ncbi Adjuvant antiestrogen treatment with tamoxifen in postmenopausal women with breast cancer: a longitudinal study of blood coagulation and fibrinolysis
    C Oberhoff
    Center of Gynecology and Obstetrics, University Hospital Essen, Germany
    Breast Cancer Res Treat 50:73-81. 1998
  4. ncbi Topotecan chemotherapy in patients with breast cancer and brain metastases: results of a pilot study
    C Oberhoff
    Abteilung für Gynäkologie, Zentrum fur Frauenheilkunde und Geburtshilfe, Universitatsklinikum Essen, Hufelandstrasse 55, D 45122 Essen, Germany
    Onkologie 24:256-60. 2001
  5. ncbi Hemostatic effects of high-dose megestrol acetate therapy in patients with advanced gynecological cancer
    C Oberhoff
    University Hospital Essen, Center of Gynecology and Obstetrics, Department of Gynecological Oncology, Hufelandstr. 55, D-45122 Essen, Germany
    Gynecol Endocrinol 15:341-8. 2001
  6. ncbi Investigation of bioavailability and pharmacokinetics of treosulfan capsules in patients with relapsed ovarian cancer
    R A Hilger
    Innere Klinik und Poliklinik Tumorforschung, Universitatsklinikum Essen, Westdeutsches Tumorzentrum, Germany
    Cancer Chemother Pharmacol 45:483-8. 2000
  7. ncbi High-dose chemotherapy with peripheral blood stem cell transplantation for patients with advanced ovarian cancer
    P Bojko
    University of Essen, Department of Internal Medicine, West German Cancer Center, Hufelandstrasse 55, 45122 Essen, Germany
    J Cancer Res Clin Oncol 127:243-50. 2001
  8. ncbi Phase I/II study of capecitabine and vinorelbine in pretreated patients with metastatic breast cancer
    A Welt
    Department of Internal Medicine (Cancer Research, West German Cancer Center, University of Duisburg-Essen Medical School, Essen, Germany
    Ann Oncol 16:64-9. 2005
  9. ncbi [Pros and cons of early cancer detection in breast carcinoma]
    R Callies
    Klinik fur Frauenheilkunde und Geburtshilfe, Universitatsklinikum Essen
    MMW Fortschr Med 147:30-2. 2005
  10. ncbi A summary of two clinical studies on tumor cell dissemination in primary and metastatic breast cancer: methods, prognostic significance and implication for alternative treatment protocols (Review)
    S Kasimir-Bauer
    Department of Internal Medicine Cancer Research, West German Cancer Center, Essen
    Int J Oncol 20:1027-34. 2002

Collaborators

Detail Information

Publications12

  1. ncbi Pharmacokinetics (PK) of a liposomal encapsulated fraction containing doxorubicin and of doxorubicin released from the liposomal capsule after intravenous infusion of Caelyx/Doxil
    R A Hilger
    Department of Internal Medicine (Cancer Research, University of Essen Medical School, West German Cancer Center, Essen, Germany
    Int J Clin Pharmacol Ther 43:588-9. 2005
  2. ncbi Recombinant human erythropoietin in the treatment of chemotherapy-induced anemia and prevention of transfusion requirement associated with solid tumors: a randomized, controlled study
    C Oberhoff
    Center for Gynecology and Obstetrics, University Hospital, Essen, Germany
    Ann Oncol 9:255-60. 1998
    ..Recombinant human erythropoietin (rhEPO) provides a new treatment modality for chemotherapy-induced anemia...
  3. ncbi Adjuvant antiestrogen treatment with tamoxifen in postmenopausal women with breast cancer: a longitudinal study of blood coagulation and fibrinolysis
    C Oberhoff
    Center of Gynecology and Obstetrics, University Hospital Essen, Germany
    Breast Cancer Res Treat 50:73-81. 1998
    ..Therefore our results are likely to reflect only the resolution of postoperative activation and do not translate into a drug related thrombogenic effect...
  4. ncbi Topotecan chemotherapy in patients with breast cancer and brain metastases: results of a pilot study
    C Oberhoff
    Abteilung für Gynäkologie, Zentrum fur Frauenheilkunde und Geburtshilfe, Universitatsklinikum Essen, Hufelandstrasse 55, D 45122 Essen, Germany
    Onkologie 24:256-60. 2001
    ..To evaluate the role of topotecan as a primary chemotherapy for brain metastases, we performed a pilot study in patients with metastatic breast cancer...
  5. ncbi Hemostatic effects of high-dose megestrol acetate therapy in patients with advanced gynecological cancer
    C Oberhoff
    University Hospital Essen, Center of Gynecology and Obstetrics, Department of Gynecological Oncology, Hufelandstr. 55, D-45122 Essen, Germany
    Gynecol Endocrinol 15:341-8. 2001
    ..The observed incidence of thrombosis might be the consequence of other risk factors such as tumor-induced hypercoagulability, simultaneous chemotherapy or other individual thrombosis risk factors...
  6. ncbi Investigation of bioavailability and pharmacokinetics of treosulfan capsules in patients with relapsed ovarian cancer
    R A Hilger
    Innere Klinik und Poliklinik Tumorforschung, Universitatsklinikum Essen, Westdeutsches Tumorzentrum, Germany
    Cancer Chemother Pharmacol 45:483-8. 2000
    ..v.) treosulfan of 1.5 or 2.0 g daily for 5 to 8 days...
  7. ncbi High-dose chemotherapy with peripheral blood stem cell transplantation for patients with advanced ovarian cancer
    P Bojko
    University of Essen, Department of Internal Medicine, West German Cancer Center, Hufelandstrasse 55, 45122 Essen, Germany
    J Cancer Res Clin Oncol 127:243-50. 2001
    ..We report the results of high-dose chemotherapy (HDC) with peripheral blood stem cell transplantation in twenty-one patients with primarily advanced or relapsed ovarian cancer...
  8. ncbi Phase I/II study of capecitabine and vinorelbine in pretreated patients with metastatic breast cancer
    A Welt
    Department of Internal Medicine (Cancer Research, West German Cancer Center, University of Duisburg-Essen Medical School, Essen, Germany
    Ann Oncol 16:64-9. 2005
    ....
  9. ncbi [Pros and cons of early cancer detection in breast carcinoma]
    R Callies
    Klinik fur Frauenheilkunde und Geburtshilfe, Universitatsklinikum Essen
    MMW Fortschr Med 147:30-2. 2005
    ..Whether this actually succeeds depends upon the quality of the early detection strategies employed. Currently the data on reduction of mortality by mammographic screening remain ambivalent...
  10. ncbi A summary of two clinical studies on tumor cell dissemination in primary and metastatic breast cancer: methods, prognostic significance and implication for alternative treatment protocols (Review)
    S Kasimir-Bauer
    Department of Internal Medicine Cancer Research, West German Cancer Center, Essen
    Int J Oncol 20:1027-34. 2002
    ..Immunotherapeutic target antigens on the cell surface of these cells support the idea that a combined chemoimmunotherapy might be successful in eliminating minimal residual disease...
  11. ncbi Is first-line single-agent mitoxantrone in the treatment of high-risk metastatic breast cancer patients as effective as combination chemotherapy? No difference in survival but higher quality of life were found in a multicenter randomized trial
    E Heidemann
    Department of Hematology and Medical Oncology, Deaconess Hospital, Oncological Center of Stuttgart, Germany
    Ann Oncol 13:1717-29. 2002
    ..To determine whether patients with high-risk metastatic breast cancer draw benefit from combination chemotherapy as first-line treatment...
  12. ncbi Epoetin beta (NeoRecormon) therapy in patients with solid tumours receiving platinum and non-platinum chemotherapy: a meta-analysis
    M Boogaerts
    University Hospital Gasthuisberg, Leuven, Belgium
    Anticancer Res 26:479-84. 2006
    ..Anaemia is a common complication of chemotherapy (CT), including both non-platinum (Pt)-based as well as Pt-based CT...